Skip to main content
Post-Event Recordings
Schedule
Full Schedule
Browse By Date
Friday, October 14, 2022
Saturday, October 15, 2022
Sunday, October 16, 2022
Monday, October 17, 2022
Tuesday, October 18, 2022
Wednesday, October 19, 2022
Thursday, October 20, 2022
Browse By Track
Browse by Session Type
Browse By Speaker
Career Development
Poster Abstracts
Browse by Title
Browse By Date
Browse by Author
Browse By Track
Sponsors and Exhibitors
Floor Plan
Browse by Company
Browse by Booths
Awards
Toggle navigation
Login
Search
Home
Post-Event Recordings
+
Schedule
Full Schedule
+
Browse By Date
Friday, October 14, 2022
Saturday, October 15, 2022
Sunday, October 16, 2022
Monday, October 17, 2022
Tuesday, October 18, 2022
Wednesday, October 19, 2022
Thursday, October 20, 2022
Browse By Track
Browse by Session Type
Browse By Speaker
Career Development
+
Poster Abstracts
Browse by Title
Browse By Date
Browse by Author
Browse By Track
+
Sponsors and Exhibitors
Floor Plan
Browse by Company
Browse by Booths
Awards
Tweets by 2022 PharmSci 360 Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
0
Like
Facebook
Tweet
Print
Clinical Pharmacology – Chemical
Session: Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)
Perspectives on the MIDD Aspects in Development of New Drugs During the COVID-19 Pandemic
Monday, October 17, 2022
10:00 AM – 10:30 AM
ET
Location: 151 AB
Government Speaker(s)
Eliford Ngaimisi Kitabi, PhD
Pharmacometrics reviewer
FDA
Handouts
None
Learning Objectives:
Define model informed drug development (MIDD)
State different aspects of MIDD
Familiarize with examples of different aspects of MIDD during the covid-19 pandemic
Develop personal opinions on the different aspects of MIDD